1 |
SIGMAR1
💬
| 2件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Pathways of neurodegeneration - multiple diseases | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
2 |
CD52
💬
| - | Alemtuzumab
Alemtuzumab
💬
|
Alemtuzumab
| 22件: 13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬 |
3 |
TNFSF13B
💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | Belimumab
Belimumab
💬
|
Belimumab
| 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬 |
4 |
TNFSF13B
💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | Atacicept
Atacicept
💬
|
Atacicept
| 4件: 13 13, 46, 49, 66 💬 |
5 |
CYSLTR1
💬
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
6 |
CYSLTR1
💬
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction | Montelukast
Montelukast
💬
|
Montelukast
| 8件: 6 6, 13, 46, 61, 63, 85, 98, 228 💬 |
7 |
CA5B
💬
| 2件: Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Acetazolamide
Acetazolamide
💬
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 💬 |
8 |
CHRM1
💬
| 8件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Oxybutynin
Oxybutynin
💬
|
Oxybutynin
| 3件: 6 6, 13, 53 💬 |
9 |
CHRM2
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton | Oxybutynin
Oxybutynin
💬
|
Oxybutynin
| 3件: 6 6, 13, 53 💬 |
10 |
CHRM3
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Oxybutynin
Oxybutynin
💬
|
Oxybutynin
| 3件: 6 6, 13, 53 💬 |
11 |
CHRM3
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Darifenacin
Darifenacin
💬
|
Darifenacin
| 2件: 6 6, 13 💬 |
12 |
CHRM3
💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Solifenacin
Solifenacin
💬
|
Solifenacin
| 3件: 6 6, 13, 53 💬 |
13 |
CHRM4
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton | Oxybutynin
Oxybutynin
💬
|
Oxybutynin
| 3件: 6 6, 13, 53 💬 |
14 |
CHRM5
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Oxybutynin
Oxybutynin
💬
|
Oxybutynin
| 3件: 6 6, 13, 53 💬 |
15 |
CHRNA1
💬
| 2件: Virion - Lyssavirus Virion - Lyssavirus, Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
16 |
CHRNA2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
17 |
CHRNA3
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cholinergic synapse, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
18 |
CHRNA4
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
19 |
CHRNA5
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
20 |
CHRNA7
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
21 |
CHRNB1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
22 |
CHRNB2
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
23 |
CHRNB3
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
24 |
CHRNB4
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cholinergic synapse, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
25 |
CHRND
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
26 |
CHRNE
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
27 |
CHRNG
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
28 |
CLCN2
💬
| 1件: Mineral absorption Mineral absorption | Lubiprostone
Lubiprostone
💬
|
Lubiprostone
| 4件: 6 6, 13, 290, 299 💬 |
29 |
CNR1
💬
| 4件: Rap1 signaling pathway Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling | Dronabinol
Dronabinol
💬
|
Dronabinol
| 8件: 2 2, 8, 13, 36, 46, 96, 271, 298 💬 |
30 |
CNR1
💬
| 4件: Rap1 signaling pathway Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling | Nabilone
Nabilone
💬
|
Nabilone
| 3件: 6 6, 13, 127 💬 |
31 |
CNR1
💬
| 4件: Rap1 signaling pathway Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling | Cannabidiol
Cannabidiol
💬
|
Cannabidiol
| 20件: 2 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
32 |
CNR2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dronabinol
Dronabinol
💬
|
Dronabinol
| 8件: 2 2, 8, 13, 36, 46, 96, 271, 298 💬 |
33 |
CNR2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nabilone
Nabilone
💬
|
Nabilone
| 3件: 6 6, 13, 127 💬 |
34 |
CNR2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Cannabidiol
Cannabidiol
💬
|
Cannabidiol
| 20件: 2 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
35 |
ADORA1
💬
| 7件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Adenosine
Adenosine
💬
|
Adenosine
| 3件: 13 13, 58, 65 💬 |
36 |
ADORA2A
💬
| 7件: Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | Adenosine
Adenosine
💬
|
Adenosine
| 3件: 13 13, 58, 65 💬 |
37 |
ADORA2B
💬
| 5件: Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Alcoholism | Adenosine
Adenosine
💬
|
Adenosine
| 3件: 13 13, 58, 65 💬 |
38 |
ADORA3
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Adenosine
Adenosine
💬
|
Adenosine
| 3件: 13 13, 58, 65 💬 |
39 |
CSF3R
💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Filgrastim
Filgrastim
💬
|
Filgrastim
| 35件: 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
40 |
CSF3R
💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Lenograstim
Lenograstim
💬
|
Lenograstim
| 7件: 2 2, 13, 16, 18, 19, 57, 65 💬 |
41 |
ADRA1D
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Tamsulosin
Tamsulosin
💬
|
Tamsulosin
| 1件: 13 13 💬 |
42 |
ADRA1B
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Tamsulosin
Tamsulosin
💬
|
Tamsulosin
| 1件: 13 13 💬 |
43 |
ADRA1A
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Silodosin
Silodosin
💬
|
Silodosin
| 2件: 6 6, 13 💬 |
44 |
ADRA1A
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Alfuzosin
Alfuzosin
💬
|
Alfuzosin
| 1件: 13 13 💬 |
45 |
ADRA1A
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | Tamsulosin
Tamsulosin
💬
|
Tamsulosin
| 1件: 13 13 💬 |
46 |
ADRA2A
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Guanabenz
Guanabenz
💬
|
Guanabenz
| 2件: 2 2, 13 💬 |
47 |
ADRA2A
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Brimonidine
Brimonidine
💬
|
Brimonidine
| 2件: 13 13, 90 💬 |
48 |
ADRA2A
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Tizanidine
Tizanidine
💬
|
Tizanidine
| 1件: 13 13 💬 |
49 |
ADRA2B
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Guanabenz
Guanabenz
💬
|
Guanabenz
| 2件: 2 2, 13 💬 |
50 |
ADRA2B
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Brimonidine
Brimonidine
💬
|
Brimonidine
| 2件: 13 13, 90 💬 |
51 |
ADRA2B
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Tizanidine
Tizanidine
💬
|
Tizanidine
| 1件: 13 13 💬 |
52 |
ADRA2C
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Guanabenz
Guanabenz
💬
|
Guanabenz
| 2件: 2 2, 13 💬 |
53 |
ADRA2C
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Brimonidine
Brimonidine
💬
|
Brimonidine
| 2件: 13 13, 90 💬 |
54 |
ADRA2C
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Tizanidine
Tizanidine
💬
|
Tizanidine
| 1件: 13 13 💬 |
55 |
ADRB2
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Albuterol
Albuterol
💬
|
Salbutamol
| 12件: 3 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬 |
56 |
ADRB2
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Clenbuterol
Clenbuterol
💬
|
Clenbuterol
| 5件: 1 1, 2, 6, 13, 256 💬 |
57 |
ADRB2
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Isoxsuprine
Isoxsuprine
💬
|
Isoxsuprine
| 1件: 13 13 💬 |
58 |
ADRB3
💬
| 8件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Mirabegron
Mirabegron
💬
|
Mirabegron
| 4件: 6 6, 13, 53, 226 💬 |
59 |
CYP17A1
💬
| 6件: Steroid hormone biosynthesis Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Cortisol synthesis and secretion, Cushing syndrome | Ketoconazole
Ketoconazole
💬
|
Ketoconazole
| 3件: 8 8, 13, 75 💬 |
60 |
DDC
💬
| 9件: Tyrosine metabolism Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism | Carbidopa
Carbidopa
💬
|
Carbidopa
| 7件: 6 6, 13, 17, 90, 140, 164, 201 💬 |
61 |
DHFR
💬
| 5件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Metabolic pathways, Biosynthesis of cofactors, Antifolate resistance | Methotrexate
Methotrexate
💬
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
62 |
DHODH
💬
| 3件: Pyrimidine metabolism Pyrimidine metabolism, Metabolic pathways, Biosynthesis of cofactors | Teriflunomide
Teriflunomide
💬
|
Teriflunomide
| 3件: 13 13, 25, 26 💬 |
63 |
NQO1
💬
| 7件: Ubiquinone and other terpenoid-quinone biosynthesis Ubiquinone and other terpenoid-quinone biosynthesis, Metabolic pathways, Biosynthesis of cofactors, Pathways in cancer, Chemical carcinogenesis - reactive oxygen species, Hepatocellular carcinoma, Fluid shear stress and atherosclerosis | Warfarin
Warfarin
💬
|
Warfarin
| 11件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 💬 |
64 |
DNMT1
💬
| 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer | Decitabine
Decitabine
💬
|
Decitabine
| 3件: 13 13, 60, 63 💬 |
65 |
DNMT3A
💬
| 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer | Decitabine
Decitabine
💬
|
Decitabine
| 3件: 13 13, 60, 63 💬 |
66 |
DNMT3B
💬
| 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer | Decitabine
Decitabine
💬
|
Decitabine
| 3件: 13 13, 60, 63 💬 |
67 |
DRD2
💬
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | Domperidone
Domperidone
💬
|
Domperidone
| 5件: 6 6, 13, 17, 51, 230 💬 |
68 |
DRD2
💬
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | Domperidone maleate
Domperidone maleate
💬
|
Domperidone
| 5件: 6 6, 13, 17, 51, 230 💬 |
69 |
DRD2
💬
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | Quetiapine
Quetiapine
💬
|
Quetiapine
| 2件: 6 6, 13 💬 |
70 |
ABAT
💬
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, Propanoate metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse | Valproic acid
Valproic acid
💬
|
Valproic acid
| 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬 |
71 |
S1PR1
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Fingolimod
Fingolimod
💬
|
Fingolimod
| 3件: 13 13, 14, 156 💬 |
72 |
S1PR1
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
73 |
S1PR1
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ponesimod
Ponesimod
💬
|
Ponesimod
| 1件: 13 13 💬 |
74 |
S1PR1
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Siponimod
Siponimod
💬
|
Siponimod
| 2件: 13 13, 50 💬 |
75 |
S1PR3
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
76 |
ELANE
💬
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Transcriptional misregulation in cancer, Systemic lupus erythematosus | Sivelestat
Sivelestat
💬
|
Sivelestat
| 3件: 13 13, 85, 96 💬 |
77 |
DHFR2
💬
| 5件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Metabolic pathways, Biosynthesis of cofactors, Antifolate resistance | Methotrexate
Methotrexate
💬
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
78 |
ESR1
💬
| 9件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | Estradiol
Estradiol
💬
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 💬 |
79 |
ESR1
💬
| 9件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | Estriol
Estriol
💬
|
Estriol
| 2件: 13 13, 227 💬 |
80 |
ESR1
💬
| 9件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | Ethinyl estradiol
Ethinyl estradiol
💬
|
Ethinylestradiol
| 4件: 13 13, 46, 49, 299 💬 |
81 |
ESR1
💬
| 9件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | Estriol tripropionate
Estriol tripropionate
💬
|
Estriol
| 2件: 13 13, 227 💬 |
82 |
ESR2
💬
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | Estradiol
Estradiol
💬
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 💬 |
83 |
ESR2
💬
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | Estriol
Estriol
💬
|
Estriol
| 2件: 13 13, 227 💬 |
84 |
ESR2
💬
| 7件: Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | Estriol tripropionate
Estriol tripropionate
💬
|
Estriol
| 2件: 13 13, 227 💬 |
85 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Zoledronic acid
Zoledronic acid
💬
|
Zoledronic acid
| 13件: 5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 💬 |
86 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Zoledronic acid
Zoledronic acid
💬
|
Zoledronic acid
| 13件: 5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 💬 |
87 |
FGFR2
💬
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | Palifermin
Palifermin
💬
|
Palifermin
| 5件: 13 13, 36, 38, 39, 65 💬 |
88 |
NCSTN
💬
| 2件: Notch signaling pathway Notch signaling pathway, Alzheimer disease | Tarenflurbil
Tarenflurbil
💬
|
Tarenflurbil
| 1件: 13 13 💬 |
89 |
CA14
💬
| 2件: Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Acetazolamide
Acetazolamide
💬
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 💬 |
90 |
MTOR
💬
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, Autophagy - other, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Cellular senescence, Apelin signaling pathway, Neutrophil extracellular trap formation, JAK-STAT signaling pathway, Th17 cell differentiation, Thermogenesis, Insulin signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Growth hormone synthesis, secretion and action, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Pancreatic cancer, Glioma, Prostate cancer, Acute myeloid leukemia, Breast cancer, Hepatocellular carcinoma, Gastric cancer, Central carbon metabolism in cancer, Choline metabolism in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Diabetic cardiomyopathy | Sirolimus
Sirolimus
💬
|
Sirolimus
| 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬 |
91 |
MTOR
💬
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, Autophagy - other, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Cellular senescence, Apelin signaling pathway, Neutrophil extracellular trap formation, JAK-STAT signaling pathway, Th17 cell differentiation, Thermogenesis, Insulin signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Growth hormone synthesis, secretion and action, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Pancreatic cancer, Glioma, Prostate cancer, Acute myeloid leukemia, Breast cancer, Hepatocellular carcinoma, Gastric cancer, Central carbon metabolism in cancer, Choline metabolism in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Diabetic cardiomyopathy | Temsirolimus
Temsirolimus
💬
|
Temsirolimus
| 1件: 13 13 💬 |
92 |
GABBR1
💬
| 7件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | Baclofen
Baclofen
💬
|
Baclofen
| 8件: 2 2, 10, 13, 18, 65, 70, 149, 206 💬 |
93 |
GABBR1
💬
| 7件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | Arbaclofen placarbil
Arbaclofen placarbil
💬
|
Arbaclofen Placarbil
| 1件: 13 13 💬 |
94 |
GABBR1
💬
| 7件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | Arbaclofen
Arbaclofen
💬
|
Arbaclofen
| 2件: 13 13, 206 💬 |
95 |
GABRA1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
96 |
GABRA1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
97 |
GABRA1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
98 |
GABRA2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
99 |
GABRA2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
100 |
GABRA2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
101 |
GABRA3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
102 |
GABRA3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
103 |
GABRA3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
104 |
GABRA4
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
105 |
GABRA4
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
106 |
GABRA4
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
107 |
GABRA5
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
108 |
GABRA5
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
109 |
GABRA5
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
110 |
GABRA6
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
111 |
GABRA6
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
112 |
GABRA6
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
113 |
GABRB1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
114 |
GABRB1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
115 |
GABRB1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
116 |
GABRB2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
117 |
GABRB2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
118 |
GABRB2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
119 |
GABRB3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
120 |
GABRB3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
121 |
GABRB3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
122 |
GABRD
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
123 |
GABRD
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
124 |
GABRD
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
125 |
GABRE
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
126 |
GABRE
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
127 |
GABRE
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
128 |
GABRG1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
129 |
GABRG1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
130 |
GABRG1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
131 |
GABRG2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
132 |
GABRG2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
133 |
GABRG2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
134 |
GABRG3
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
135 |
GABRG3
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
136 |
GABRG3
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
137 |
GABRP
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
138 |
GABRP
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
139 |
GABRP
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
140 |
GAD1
💬
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, beta-Alanine metabolism, Taurine and hypotaurine metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse, Type I diabetes mellitus | Valproic acid
Valproic acid
💬
|
Valproic acid
| 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬 |
141 |
GAD2
💬
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, beta-Alanine metabolism, Taurine and hypotaurine metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse, Type I diabetes mellitus | Valproic acid
Valproic acid
💬
|
Valproic acid
| 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬 |
142 |
ABL1
💬
| 11件: ErbB signaling pathway ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, MicroRNAs in cancer, Chemical carcinogenesis - reactive oxygen species, Chronic myeloid leukemia, Viral myocarditis | Imatinib
Imatinib
💬
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
143 |
GHRHR
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Growth hormone synthesis, secretion and action | Somatorelin
Somatorelin
💬
|
Somatorelin
| 2件: 13 13, 78 💬 |
144 |
GLP1R
💬
| 3件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion | Dulaglutide
Dulaglutide
💬
|
Dulaglutide
| 2件: 13 13, 299 💬 |
145 |
GRIA1
💬
| 14件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
146 |
GRIA2
💬
| 15件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
147 |
GRIA3
💬
| 13件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction, Transcriptional misregulation in cancer | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
148 |
GRIA4
💬
| 10件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Huntington disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
149 |
GRIK1
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
150 |
GRIK2
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
151 |
GRIK3
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
152 |
GRIK4
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
153 |
GRIK5
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
154 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
155 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
156 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Amantadine
Amantadine
💬
|
Amantadine
| 4件: 6 6, 8, 13, 127 💬 |
157 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
158 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Memantine
Memantine
💬
|
Memantine
| 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 💬 |
159 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
160 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
161 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Amantadine
Amantadine
💬
|
Amantadine
| 4件: 6 6, 8, 13, 127 💬 |
162 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
163 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Memantine
Memantine
💬
|
Memantine
| 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 💬 |
164 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
165 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
166 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Amantadine
Amantadine
💬
|
Amantadine
| 4件: 6 6, 8, 13, 127 💬 |
167 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
168 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Memantine
Memantine
💬
|
Memantine
| 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 💬 |
169 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
170 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
171 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Amantadine
Amantadine
💬
|
Amantadine
| 4件: 6 6, 8, 13, 127 💬 |
172 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
173 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Memantine
Memantine
💬
|
Memantine
| 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 💬 |
174 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Riluzole
Riluzole
💬
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
175 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
176 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Amantadine
Amantadine
💬
|
Amantadine
| 4件: 6 6, 8, 13, 127 💬 |
177 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
178 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Memantine
Memantine
💬
|
Memantine
| 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 💬 |
179 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone
Dexamethasone
💬
|
Dexamethasone
| 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬 |
180 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone
Methylprednisolone
💬
|
Methylprednisolone
| 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
181 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisolone
Prednisolone
💬
|
Prednisolone
| 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
182 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisone
Prednisone
💬
|
Prednisone
| 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 |
183 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinate
💬
|
Methylprednisolone hemisuccinate
| 7件: 13 13, 49, 50, 51, 53, 97, 211 💬 |
184 |
HCRTR1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Suvorexant
Suvorexant
💬
|
Suvorexant
| 3件: 5 5, 6, 13 💬 |
185 |
HCRTR2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Suvorexant
Suvorexant
💬
|
Suvorexant
| 3件: 5 5, 6, 13 💬 |
186 |
HMGCR
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | Simvastatin
Simvastatin
💬
|
Simvastatin
| 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
187 |
HMGCR
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | Atorvastatin
Atorvastatin
💬
|
Atorvastatin
| 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬 |
188 |
HMGCR
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | Pravastatin
Pravastatin
💬
|
Pravastatin
| 9件: 13 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
189 |
HPRT1
💬
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Tioguanine
Tioguanine
💬
|
Tioguanine
| 2件: 13 13, 37 💬 |
190 |
HRH1
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Diphenhydramine
Diphenhydramine
💬
|
Diphenhydramine
| 8件: 11 11, 13, 49, 51, 70, 86, 222, 256 💬 |
191 |
HRH1
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Loratadine
Loratadine
💬
|
Loratadine
| 4件: 13 13, 46, 89, 98 💬 |
192 |
HRH1
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Clemastine
Clemastine
💬
|
Clemastine
| 1件: 13 13 💬 |
193 |
HRH1
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Desloratadine
Desloratadine
💬
|
Desloratadine
| 1件: 13 13 💬 |
194 |
HRH1
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Cetirizine
Cetirizine
💬
|
Cetirizine
| 4件: 13 13, 28, 35, 300 💬 |
195 |
HRH1
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Dexchlorpheniramine
Dexchlorpheniramine
💬
|
Dexchlorpheniramine
| 2件: 13 13, 49 💬 |
196 |
HRH1
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Fexofenadine
Fexofenadine
💬
|
Fexofenadine
| 2件: 13 13, 46 💬 |
197 |
HRH2
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion | Ranitidine
Ranitidine
💬
|
Ranitidine
| 2件: 13 13, 65 💬 |
198 |
HTR2A
💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | Cisapride
Cisapride
💬
|
Cisapride
| 1件: 13 13 💬 |
199 |
HTR2A
💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | Cisapride
Cisapride
💬
|
Cisapride
| 1件: 13 13 💬 |
200 |
HTR2A
💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | Quetiapine
Quetiapine
💬
|
Quetiapine
| 2件: 6 6, 13 💬 |
201 |
HTR3A
💬
| 2件: Serotonergic synapse Serotonergic synapse, Taste transduction | Cisapride
Cisapride
💬
|
Cisapride
| 1件: 13 13 💬 |
202 |
HTR3A
💬
| 2件: Serotonergic synapse Serotonergic synapse, Taste transduction | Cisapride
Cisapride
💬
|
Cisapride
| 1件: 13 13 💬 |
203 |
HTR4
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse | Cisapride
Cisapride
💬
|
Cisapride
| 1件: 13 13 💬 |
204 |
HTR4
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse | Cisapride
Cisapride
💬
|
Cisapride
| 1件: 13 13 💬 |
205 |
HTR4
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse | Prucalopride
Prucalopride
💬
|
Prucalopride
| 3件: 13 13, 51, 96 💬 |
206 |
IFNAR1
💬
| 18件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon beta-1b
Interferon beta-1b
💬
|
Interferon beta-1b
| 1件: 13 13 💬 |
207 |
IFNAR1
💬
| 18件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon alfa
Interferon alfa
💬
|
Interferon alfa
| 6件: 13 13, 25, 26, 28, 56, 96 💬 |
208 |
IFNAR1
💬
| 18件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon beta-1a
Interferon beta-1a
💬
|
Interferon beta-1a
| 4件: 13 13, 26, 96, 97 💬 |
209 |
IFNAR1
💬
| 18件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Peginterferon beta-1a
Peginterferon beta-1a
💬
|
Peginterferon beta-1a
| 1件: 13 13 💬 |
210 |
IFNAR2
💬
| 17件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon beta-1b
Interferon beta-1b
💬
|
Interferon beta-1b
| 1件: 13 13 💬 |
211 |
IFNAR2
💬
| 17件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon alfa
Interferon alfa
💬
|
Interferon alfa
| 6件: 13 13, 25, 26, 28, 56, 96 💬 |
212 |
IFNAR2
💬
| 17件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon beta-1a
Interferon beta-1a
💬
|
Interferon beta-1a
| 4件: 13 13, 26, 96, 97 💬 |
213 |
IFNAR2
💬
| 17件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Peginterferon beta-1a
Peginterferon beta-1a
💬
|
Peginterferon beta-1a
| 1件: 13 13 💬 |
214 |
IL1A
💬
| 21件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Necroptosis, Cellular senescence, Osteoclast differentiation, Hematopoietic cell lineage, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Type I diabetes mellitus, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pertussis, Leishmaniasis, Tuberculosis, Measles, Influenza A, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Fluid shear stress and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
215 |
IL1B
💬
| 44件: Antifolate resistance Antifolate resistance, MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th17 cell differentiation, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Human cytomegalovirus infection, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
216 |
IL1R1
💬
| 13件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Hematopoietic cell lineage, Th17 cell differentiation, Inflammatory mediator regulation of TRP channels, Pathogenic Escherichia coli infection, Shigellosis, Amoebiasis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Fluid shear stress and atherosclerosis | Anakinra
Anakinra
💬
|
Anakinra
| 18件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬 |
217 |
IL2RA
💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Endocytosis, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer | Daclizumab
Daclizumab
💬
|
Daclizumab
| 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 💬 |
218 |
IL6
💬
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Antifolate resistance, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, Cellular senescence, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th17 cell differentiation, TNF signaling pathway, Intestinal immune network for IgA production, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Chagas disease, African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Transcriptional misregulation in cancer, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Hypertrophic cardiomyopathy, Lipid and atherosclerosis | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
219 |
IL6R
💬
| 12件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, HIF-1 signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th17 cell differentiation, Non-alcoholic fatty liver disease, Human cytomegalovirus infection, Coronavirus disease - COVID-19, Pathways in cancer | Tocilizumab
Tocilizumab
💬
|
Tocilizumab
| 21件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
220 |
IL6R
💬
| 12件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, HIF-1 signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th17 cell differentiation, Non-alcoholic fatty liver disease, Human cytomegalovirus infection, Coronavirus disease - COVID-19, Pathways in cancer | Satralizumab
Satralizumab
💬
|
Satralizumab
| 3件: 11 11, 13, 86 💬 |
221 |
IL10
💬
| 22件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, FoxO signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Pertussis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Staphylococcus aureus infection, Tuberculosis, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Systemic lupus erythematosus, Allograft rejection | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
222 |
IL17A
💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Secukinumab
Secukinumab
💬
|
Secukinumab
| 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 💬 |
223 |
IMPDH1
💬
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolate mofetil
Mycophenolate mofetil
💬
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
224 |
IMPDH1
💬
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolic acid
Mycophenolic acid
💬
|
Mycophenolic acid
| 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
225 |
IMPDH2
💬
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolate mofetil
Mycophenolate mofetil
💬
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
226 |
IMPDH2
💬
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolic acid
Mycophenolic acid
💬
|
Mycophenolic acid
| 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
227 |
ITGA4
💬
| 14件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Firategrast
Firategrast
💬
|
Firategrast
| 1件: 13 13 💬 |
228 |
ITGA4
💬
| 14件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Natalizumab
Natalizumab
💬
|
Natalizumab
| 6件: 13 13, 15, 25, 46, 63, 96 💬 |
229 |
AR
💬
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | Testosterone
Testosterone
💬
|
Testosterone
| 8件: 1 1, 2, 3, 13, 60, 76, 78, 113 💬 |
230 |
AR
💬
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | Testosterone undecanoate
Testosterone undecanoate
💬
|
Testosterone undecanoate
| 2件: 13 13, 60 💬 |
231 |
ITGAL
💬
| 12件: Rap1 signaling pathway Rap1 signaling pathway, Cell adhesion molecules, Neutrophil extracellular trap formation, Natural killer cell mediated cytotoxicity, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Malaria, Staphylococcus aureus infection, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis | Efalizumab
Efalizumab
💬
|
Efalizumab
| 9件: 11 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
232 |
KCNA4
💬
| 2件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
233 |
KCNC3
💬
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
234 |
KCND2
💬
| 1件: Serotonergic synapse Serotonergic synapse | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
235 |
KCND3
💬
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
236 |
KCNJ11
💬
| 3件: Insulin secretion Insulin secretion, GnRH secretion, Type II diabetes mellitus | Diazoxide
Diazoxide
💬
|
Diazoxide
| 2件: 13 13, 193 💬 |
237 |
CA13
💬
| 2件: Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Acetazolamide
Acetazolamide
💬
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 💬 |
238 |
KIT
💬
| 11件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Melanogenesis, Pathways in cancer, Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer | Imatinib
Imatinib
💬
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
239 |
KIT
💬
| 11件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Melanogenesis, Pathways in cancer, Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer | Masitinib
Masitinib
💬
|
Masitinib
| 6件: 2 2, 5, 6, 13, 46, 96 💬 |
240 |
LTB
💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis | Baminercept
Baminercept
💬
|
Baminercept
| 4件: 13 13, 46, 53, 97 💬 |
241 |
MC2R
💬
| 5件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome | Corticotropin
Corticotropin
💬
|
Corticotropin
| 12件: 2 2, 13, 14, 46, 49, 50, 66, 75, 81, 84, 145, 222 💬 |
242 |
ACHE
💬
| 2件: Glycerophospholipid metabolism Glycerophospholipid metabolism, Cholinergic synapse | Rivastigmine
Rivastigmine
💬
|
Rivastigmine
| 3件: 5 5, 6, 13 💬 |
243 |
ACHE
💬
| 2件: Glycerophospholipid metabolism Glycerophospholipid metabolism, Cholinergic synapse | Donepezil
Donepezil
💬
|
Donepezil
| 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 💬 |
244 |
MTNR1A
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬 |
245 |
MTNR1B
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬 |
246 |
ATP4A
💬
| 4件: Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secretion | Pantoprazole
Pantoprazole
💬
|
Pantoprazole
| 2件: 13 13, 65 💬 |
247 |
ATP4A
💬
| 4件: Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secretion | Esomeprazole
Esomeprazole
💬
|
Esomeprazole
| 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 💬 |
248 |
ATP4B
💬
| 4件: Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secretion | Pantoprazole
Pantoprazole
💬
|
Pantoprazole
| 2件: 13 13, 65 💬 |
249 |
ATP4B
💬
| 4件: Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secretion | Esomeprazole
Esomeprazole
💬
|
Esomeprazole
| 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 💬 |
250 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
251 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Oxycodone
Oxycodone
💬
|
Oxycodone
| 5件: 6 6, 13, 70, 226, 298 💬 |
252 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Loperamide
Loperamide
💬
|
Loperamide
| 2件: 13 13, 97 💬 |
253 |
OPRK1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
254 |
OPRK1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Oxycodone
Oxycodone
💬
|
Oxycodone
| 5件: 6 6, 13, 70, 226, 298 💬 |
255 |
OPRK1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Loperamide
Loperamide
💬
|
Loperamide
| 2件: 13 13, 97 💬 |
256 |
OPRM1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
257 |
OPRM1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | Oxycodone
Oxycodone
💬
|
Oxycodone
| 5件: 6 6, 13, 70, 226, 298 💬 |
258 |
OPRM1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | Loperamide
Loperamide
💬
|
Loperamide
| 2件: 13 13, 97 💬 |
259 |
APH1A
💬
| 2件: Notch signaling pathway Notch signaling pathway, Alzheimer disease | Tarenflurbil
Tarenflurbil
💬
|
Tarenflurbil
| 1件: 13 13 💬 |
260 |
PDCD1
💬
| 3件: Cell adhesion molecules Cell adhesion molecules, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Nivolumab
Nivolumab
💬
|
Nivolumab
| 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
261 |
PDE3A
💬
| 6件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, cAMP signaling pathway, Renin secretion, Morphine addiction | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
262 |
PDE3B
💬
| 11件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, cAMP signaling pathway, Apelin signaling pathway, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Glucagon signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
263 |
PDE4A
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
264 |
PDE4A
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Rolipram
Rolipram
💬
|
Rolipram
| 2件: 8 8, 13 💬 |
265 |
PDE4B
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
266 |
PDE4B
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Rolipram
Rolipram
💬
|
Rolipram
| 2件: 8 8, 13 💬 |
267 |
PDE4C
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
268 |
PDE4C
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Rolipram
Rolipram
💬
|
Rolipram
| 2件: 8 8, 13 💬 |
269 |
PDE4D
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
270 |
PDE4D
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Rolipram
Rolipram
💬
|
Rolipram
| 2件: 8 8, 13 💬 |
271 |
PDGFRA
💬
| 20件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Phospholipase D signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, JAK-STAT signaling pathway, Regulation of actin cytoskeleton, Human cytomegalovirus infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer | Imatinib
Imatinib
💬
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
272 |
PGR
💬
| 5件: Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | Norethindrone
Norethindrone
💬
|
Norethisterone
| 4件: 13 13, 46, 49, 299 💬 |
273 |
PGR
💬
| 5件: Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | Levonorgestrel
Levonorgestrel
💬
|
Levonorgestrel
| 1件: 13 13 💬 |
274 |
PGR
💬
| 5件: Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | Medroxyprogesterone acetate
Medroxyprogesterone acetate
💬
|
Medroxyprogesterone acetate
| 8件: 13 13, 35, 46, 49, 50, 51, 60, 107 💬 |
275 |
PGR
💬
| 5件: Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | Dydrogesterone
Dydrogesterone
💬
|
Dydrogesterone
| 1件: 13 13 💬 |
276 |
PGR
💬
| 5件: Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | Nomegestrol
Nomegestrol
💬
|
Nomegestrol
| 1件: 13 13 💬 |
277 |
PGR
💬
| 5件: Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | Nomegestrol acetate
Nomegestrol acetate
💬
|
Nomegestrol acetate
| 1件: 13 13 💬 |
278 |
S1PR5
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
279 |
S1PR5
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Siponimod
Siponimod
💬
|
Siponimod
| 2件: 13 13, 50 💬 |
280 |
PPARG
💬
| 11件: PPAR signaling pathway PPAR signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Osteoclast differentiation, Thermogenesis, Non-alcoholic fatty liver disease, Huntington disease, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Lipid and atherosclerosis | Pioglitazone
Pioglitazone
💬
|
Pioglitazone
| 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
281 |
PPP3CA
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
282 |
PPP3CA
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
283 |
PPP3CB
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
284 |
PPP3CB
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
285 |
PPP3CC
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
286 |
PPP3CC
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
287 |
PPP3R1
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
288 |
PPP3R1
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
289 |
PPP3R2
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
290 |
PPP3R2
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
291 |
CHRNA9
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Chemical carcinogenesis - receptor activation | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
292 |
PRKAA1
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin
Metformin
💬
|
Metformin
| 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬 |
293 |
PRKAA2
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin
Metformin
💬
|
Metformin
| 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬 |
294 |
CACNA2D3
💬
| 7件: MAPK signaling pathway MAPK signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Oxytocin signaling pathway, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Gabapentin
Gabapentin
💬
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 💬 |
295 |
CACNA2D3
💬
| 7件: MAPK signaling pathway MAPK signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Oxytocin signaling pathway, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Pregabalin
Pregabalin
💬
|
Pregabalin
| 5件: 13 13, 36, 46, 70, 298 💬 |
296 |
PSENEN
💬
| 2件: Notch signaling pathway Notch signaling pathway, Alzheimer disease | Tarenflurbil
Tarenflurbil
💬
|
Tarenflurbil
| 1件: 13 13 💬 |
297 |
GABRQ
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
298 |
GABRQ
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Flumazenil
Flumazenil
💬
|
Flumazenil
| 5件: 6 6, 13, 17, 18, 206 💬 |
299 |
GABRQ
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Eszopiclone
Eszopiclone
💬
|
Eszopiclone
| 3件: 6 6, 13, 46 💬 |
300 |
PSEN1
💬
| 6件: Wnt signaling pathway Wnt signaling pathway, Notch signaling pathway, Neurotrophin signaling pathway, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Human papillomavirus infection | Tarenflurbil
Tarenflurbil
💬
|
Tarenflurbil
| 1件: 13 13 💬 |
301 |
PSMB5
💬
| 8件: Proteasome Proteasome, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases | Bortezomib
Bortezomib
💬
|
Bortezomib
| 17件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 |
302 |
PSMB5
💬
| 8件: Proteasome Proteasome, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases | Ixazomib
Ixazomib
💬
|
Ixazomib
| 5件: 13 13, 16, 28, 51, 61 💬 |
303 |
RGMA
💬
| 2件: TGF-beta signaling pathway TGF-beta signaling pathway, Axon guidance | Elezanumab
Elezanumab
💬
|
Elezanumab
| 1件: 13 13 💬 |
304 |
CHRNA10
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nicotine
Nicotine
💬
|
Nicotine
| 3件: 6 6, 13, 84 💬 |
305 |
PTGDR
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Ramatroban
Ramatroban
💬
|
Ramatroban
| 1件: 13 13 💬 |
306 |
PTGIR
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation | Ibudilast
Ibudilast
💬
|
Ibudilast
| 2件: 2 2, 13 💬 |
307 |
PTGS1
💬
| 5件: Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | Aspirin
Aspirin
💬
|
Acetylsalicylic acid
| 14件: 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 💬 |
308 |
PTGS1
💬
| 5件: Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | Naproxen
Naproxen
💬
|
Naproxen
| 4件: 13 13, 46, 107, 271 💬 |
309 |
PTGS1
💬
| 5件: Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | Ibuprofen
Ibuprofen
💬
|
Ibuprofen
| 7件: 13 13, 46, 65, 107, 113, 271, 299 💬 |
310 |
PTGS1
💬
| 5件: Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | Acetaminophen
Acetaminophen
💬
|
Acetaminophen
| 15件: 3 3, 6, 11, 13, 34, 35, 46, |